Lenacapavir Uses, Dosage, Side Effects and more
Lenacapavir is under investigation in clinical trial NCT04150068 (Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With an Optimized Background Regimen in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance).
| Attribute | Details |
|---|---|
| Trade Name | Lenacapavir |
| Generic | Lenacapavir |
| Lenacapavir Other Names | Lenacapavir |
| Type | |
| Formula | C39H32ClF10N7O5S2 |
| Weight | Average: 968.28 Monoisotopic: 967.1435188 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
